Edgen Stock·Nov 21 2025, 21:35Back
Tango Therapeutics Advances Vopimetostat to Pivotal Trial After Positive Cancer Data
Edgen Stock·Nov 21 2025, 21:35
[1] Tango reports positive data for vopimetostat in MTAP-deleted cancers (https://www.investing.com/news/company-news/t ...)[2] Tango Therapeutics Reports Positive Data from Ongoing Phase 1/2 ... (https://www.theglobeandmail.com/investing/mar ...)[3] Why Tango Therapeutics (TNGX) Surged After Positive Vopimetostat ... (https://finance.yahoo.com/news/why-tango-ther ...)
